Clinical Metadata Luminary Frederik Malfait Joins Nurocor Team
Will drive information architecture for clinical trial lifecycle automation
RALEIGH, N.C., June 4, 2018 (Newswire.com) - Nurocor announced today that Frederik Malfait has joined the team as vice president of information architecture. Frederik will help fulfill Nurocor’s mission to bring order to clinical data. The world of clinical data is becoming increasingly complex and Nurocor believes that through disciplined management of data standards and semantics, BioPharma companies can control this complexity and turn it into a business advantage.
In this role, Frederik will drive the information architecture for Nurocor's industry-leading MDR, focusing on protocol and standards-driven clinical trial lifecycle automation. He will apply his expertise in standards and metadata technologies to help organizations deliver on the promise of clinical data standards.
“Joining Nurocor allows me to apply my expertise to help some of the world’s largest and most successful pharma and biotech companies optimize their clinical trial lifecycles,” Malfait said. “Nurocor MDR is already leading the way in implementing data standards for clinical research. At Nurocor, we believe that digital protocols and data standards driven solutions are essential and complementary to achieve significant value beyond regulatory compliance. It will enable process automation and better systems integration from protocol to submission, covering many aspects of protocol and study design, study setup, data management, statistical analysis and submission activities. Nurocor’s future information architecture based on the Nurocor MDR will be aimed at delivering this value to new and existing customers.”
For more than 20 years Frederik has been engaged in the Biotech/Pharmaceutical industry with assignments ranging across Drug Safety, Biometrics, Clinical Data Management, Statistical Programming and Data Standards. He initiated and was the co-lead of the PhUSE CSS Semantic Technology working group, has designed a semantic MDR for a large pharma and supported TransCelerate and CDISC as they developed the next generation of CDISC SHARE.
“We are delighted to have Frederik join our team,” said Alex Lazar, Nurocor president and founder. “Frederik’s experience with clinical data and technical expertise with Metadata Repositories will help us accelerate the pace of our innovation to provide more value to our customers.”
Nurocor is completely focused on addressing the standards and metadata challenges facing the BioPharma industry throughout the R&D data lifecycle. The company works with many of the world’s largest companies including Amgen, Syneos, Novartis, Pfizer and Roche, helping them bring order to clinical data to improve the quality of medical research and bring new medicines to patients more quickly.
Frederik is a perfect addition to a team that combines deep industry expertise with a proven ability to bring enterprise technology solutions to market. The Nurocor team has extensive knowledge of the BioPharma business, the R&D data lifecycle and expertise in the practical application of standards development and implementation. Driven by experienced management, technology and professional services teams, it also has an extensive track record of successfully delivering technology solutions to the enterprise.
Backed by established venture capital and private equity funds, Nurocor is uniquely positioned to address the standards and metadata challenges facing the BioPharma industry.
Nurocor helps companies like Amgen, Syneos, Novartis, Pfizer and Roche bring order to clinical data to improve the quality of medical research and bring new medicines to patients more quickly. Created by a team combining deep industry expertise with a proven ability to bring technology solutions to market, Nurocor MDR is the industry-leading standards metadata repository enabling the seamless interchange of data between Electronic Data Capture and Clinical Data Management systems and regulatory agencies.